Andelyn Biosciences
Andelyn Biosciences is a world-leading gene therapy CDMO and affiliate organization of Nationwide Children’s Hospital. AndelynBio offers full-spectrum development and manufacturing services for cGMP AAV and Plasmid DNA. Our facility currently supports both adherent and suspension bioreactor platform technologies. We provide manufacturability/feasibility assessments to de-risk your program in addition to full regulatory and technical support. From concept through Phase 3 (commercial 2022), we help advance the field of gene therapy and support the evolution of pivotal studies. Learn more at AndelynBio.com.
